China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Cohort Study on the Effects of Cenobamate as Add-on Therapy on Mood, Behavior and Cognitive Function in Adult Patients with Drug-Resistant Focal Epilepsy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135749

Registration Time: 2026/11/02

Type: Observational study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348343

Published by HT Digital Content Services with permission from Health Daily Digest....